Limaryl M 1 mg+500 mg (Tablet (Extended Release))
Unit Price: ৳ 9.00 (3 x 10: ৳ 270.00)
Strip Price: ৳ 90.00
Medicine Details
Category | Details |
---|---|
Generic | Glimepiride metformin |
Company | Popular pharmaceuticals ltd |
Also available as |
Indications
- Adjunct to diet and exercise in type 2 diabetes mellitus patients
- For inadequate glycemic control with glimepiride or metformin monotherapy
- Replacement of combination therapy of glimepiride and metformin
Pharmacology
- Decreases blood glucose concentration
- Stimulates insulin release from pancreatic beta cells
- Improves sensitivity of beta cells to glucose stimulus
- Reduces basal hepatic glucose production
- Increases peripheral tissue sensitivity to insulin
- Improves glucose uptake
- Hypoglycemic action persists for 24 hours in non-fasting diabetic patients
Dosage
- Governed by desired blood glucose level
- Must be lowest sufficient to achieve metabolic control
- Regular measurement of blood and urine glucose levels
- Avoid correcting mistakes by taking a larger dose
- Glimepiride requirements may fall as treatment proceeds
- Maximum recommended daily dose: 8mg glimepiride, 2000mg metformin
Administration
- Tablet must be swallowed whole, not crushed or chewed
Interaction
- Metabolized by CYP2C9
- Potential potentiation and hypoglycemia with coadministered drugs
- Potential weakening and raised blood glucose levels with coadministered drugs
- Alcohol intake may potentiate or weaken blood-glucose-lowering action
- Bile acid sequestrant (e.g., colesevelam) reduces glimepiride absorption
Contraindications
- Hypersensitivity to glimepiride, metformin, other sulfonylureas, sulfonamides, or excipients
- Pregnancy
- Breastfeeding
- Severe impairment of liver function
- Severe renal failure or renal dysfunction
- Acute metabolic acidosis, diabetic ketoacidosis
Side Effects
- Hypoglycemia
- Temporary visual impairment
- Gastrointestinal symptoms
- Liver enzyme elevation, cholestasis, jaundice
- Changes in blood picture
- Alopecia
- Allergic reactions
- Weight gain
- Nausea, vomiting, diarrhea, abdominal pain, loss of appetite
- Metallic taste
- Decrease of vitamin B12 absorption
- Lactic acidosis
- Hemolytic anemia
- Reduction of thyrotropin level
- Hypomagnesemia
- Encephalopathy
- Photosensitivity
Pregnancy & Lactation
- Glimepiride must not be taken during pregnancy
- Metformin not recommended during pregnancy, insulin should be used
- Glimepiride not for breastfeeding women, switch to insulin if necessary
- Metformin excreted into milk, consider the importance of the compound to the mother
Precautions & Warnings
- Increased risk of hypoglycemia in initial weeks of treatment
- Careful monitoring in risk factors for hypoglycemia
- Caution in patients with G6PD-deficiency
- Regular monitoring of TSH levels in patients with hypothyroidism
- Decrease in vitamin B12 serum levels with long-term metformin treatment
- GFR assessment before initiating metformin therapy
Use in Special Populations
- Insufficient data for pediatric use
- Renal function assessment before initiation of metformin therapy
- Maximum daily doses based on GFR levels
Overdose Effects
- Severe life-threatening hypoglycemia with glimepiride
- Immediate treatment and hospital admission for severe reactions
- Lactic acidosis, pancreatitis in metformin overdose
- Medical emergency and treatment in hospital for lactic acidosis
Therapeutic Class
- Combination Oral hypoglycemic preparations
Storage Conditions
- Store in a cool and dry place, protected from light
Related Brands
- Losucon M 1 mg+500 mg (Tablet (Sustained Release)) - incepta-pharmaceuticals-ltd
- Gemer 1 mg+500 mg (Tablet (Extended Release)) - sun-pharmaceutical-bangladesh-ltd
- Amaryl M 1 mg+500 mg (Tablet (Prolonged Release)) - synovia-pharma-plc
- Amaryl M 2 mg+500 mg (Tablet (Prolonged Release)) - synovia-pharma-plc
- Dieta M 1 mg+500 mg (Tablet (Extended Release)) - pacific-pharmaceuticals-ltd